Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23442496 | 1.00 | KDM4E (0.34) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL23442482 | 1.00 | KDM4E (0.34) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL17722229 | 0.99 | KDM4E (0.33) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL15752369 | 0.99 | KDM4E (0.33) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL23849215 | 0.99 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL17658784 | 0.98 | PDK2 (0.32) | KDM4EATML3MBTL1PDK2 | |
| SCHEMBL23442493 | 0.98 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL17598790 | 0.98 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL24083978 | 0.97 | TSPO (0.36) | KDM4EATML3MBTL1PDK2TSPO | |
| SCHEMBL15752428 | 0.97 | KDM4E (0.35) | KDM4EATML3MBTL1PDK2TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023085606-A1 | ORGANIC ELECTRIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2023-05-19 | — | — | WO | disclosed |
| US-20220407026-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-12-22 | — | — | US | disclosed |
| US-20210167298-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-06-03 | — | — | US | disclosed |
| US-20170331067-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS | SAMSUNG SDI CO., LTD. (KR) | 2017-11-16 | — | — | US | disclosed |
| US-20170331067-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS | SAMSUNG SDI CO., LTD. (KR) | 2017-11-16 | — | — | US | disclosed |
| US-20160126471-A1 | ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2016-05-05 | — | — | US | disclosed |
| US-20160126471-A1 | ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2016-05-05 | — | — | US | disclosed |
| US-20160099417-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-07 | — | — | US | disclosed |
| US-20160099417-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170331067-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY APPARATUS | ALDH1A2, AOX1, AOC2 | KDM4E 4201/4885ATM 3243/4885L3MBTL1 4413/4885 |
| US-20220407026-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | L1CAM, EPCAM, EML4 | KDM4E 1727/4885ATM 2536/4885L3MBTL1 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.